| Genomic Medicine |
1 |
1 |
| Genetics |
0 |
0.61 |
| Breast Cancer |
0 |
0.49 |
| Cancer |
0 |
0.49 |
| Prostate Cancer |
0 |
0.49 |
| Genetic Testing |
0 |
0.47 |
| Colorectal Cancer |
0 |
0.45 |
| Cancer Risk |
0 |
0.39 |
| Chronic Disease |
0 |
0.36 |
| Coronary Artery Disease (CAD) |
0 |
0.34 |
| Cardiovascular Risk Management |
0 |
0.3 |
| Primary Care |
0 |
0.24 |
| Atrial Fibrillation |
0 |
0.22 |
| Healthcare and Medical Technology |
0 |
0.19 |
| Type 2 Diabetes Mellitus |
0 |
0.19 |
| Breast |
0 |
0.18 |
| Clinical Research |
0 |
0.18 |
| Artery |
0 |
0.12 |
| Blood |
0 |
0.12 |
| Cardiovascular disease |
0 |
0.12 |
| Europe |
0 |
0.12 |
| Heart |
0 |
0.12 |
| Hospital |
0 |
0.12 |
| Prostate |
0 |
0.12 |
| NHS |
0 |
0.09 |
| Clinical Guidelines |
0 |
0.06 |
| Diet |
0 |
0.06 |
| Diversity |
0 |
0.06 |
| Epidemiology |
0 |
0.06 |
| Exercise |
0 |
0.06 |
| Health Care Services |
0 |
0.06 |
| Kidney |
0 |
0.06 |
| Lung |
0 |
0.06 |
| Massachusetts |
0 |
0.06 |
| Molecular Medicine |
0 |
0.06 |
| Sickle Cell Anemia |
0 |
0.06 |
| Smoking |
0 |
0.06 |
| Social Determinants of Health |
0 |
0.06 |
| Tobacco Cessation |
0 |
0.06 |